Dr. Matthew Dietz
Claim this profilePrimary Children's Hospital
Expert in Neuroblastoma
Expert in Cancer
33 reported clinical trials
64 drugs studied
Area of expertise
1Neuroblastoma
Global LeaderMYC positive
Stage IV
MYC negative
2Cancer
Global LeaderStage I
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Matthew Dietz is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
More about Matthew Dietz
Clinical Trial Related8 years of experience running clinical trials · Led 33 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Matthew Dietz has experience with
- Cyclophosphamide
- Vincristine
- Carboplatin
- Etoposide
- Cisplatin
- Larotrectinib
Breakdown of trials Matthew Dietz has run
Neuroblastoma
Rhabdomyosarcoma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Dietz specialize in?
Matthew Dietz focuses on Neuroblastoma and Cancer. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are Stage IV.
Is Matthew Dietz currently recruiting for clinical trials?
Yes, Matthew Dietz is currently recruiting for 10 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Matthew Dietz has studied deeply?
Yes, Matthew Dietz has studied treatments such as Cyclophosphamide, Vincristine, Carboplatin.
What is the best way to schedule an appointment with Matthew Dietz?
Apply for one of the trials that Matthew Dietz is conducting.
What is the office address of Matthew Dietz?
The office of Matthew Dietz is located at: Primary Children's Hospital, Salt Lake City, Utah 84113 United States. This is the address for their practice at the Primary Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.